Nearly 170,000 counterfeit medicinal items have been seized following a police raid in Hungary.
The lights of Oxford and Cambridge University might shine brightest, but there is more than a flicker of success at other academic institutions in the UK. One of those, the University of Manchester, boasts 25 Nobel Prize winners and has housed academic masterminds such as Alan Turing.
India has been urged once again to strengthen its IP laws, particularly those covering drugs, following a visit from the US Trade Representative.
UK medical research charity MRC Technology has teamed up with Chinese pharmaceutical company Yabao as part of an effort to discover and develop treatments for Parkinson’s disease.
US pharmaceutical company Supernus Pharmaceuticals has sued Zydus Pharmaceuticals and Cadila Healthcare accusing them of infringing patents covering its antiepileptic drug, Trokendi XR (topiramate).
Steptoe & Johnson has added a partner to its New York IP team.
A lawyer from GlaxoSmithKline has said the Unified Patent Court will take ten years to overcome teething problems.
Indian drug maker Ranbaxy Laboratories has sued the US Food and Drug Administration and claimed it wrongfully revoked a previous approval for two new drugs.
US-based law firm Quarles & Brady has expanded its life sciences team with the addition of a new partner.
The US Court of Appeals for the Federal Circuit has denied pharmaceutical company Antares Pharma an injunction that aimed to block a rival from allegedly infringing a patent covering injection devices.